Trajenta is a drug that contains the active substance Linagliptin. It is available as tablets (5 mg)
Linagliptin resides to the class of diabetes medicines called DPP-4 inhibitors. It works by increasing the amount of incretin released by the intestine. Incretin is a hormone that increases insulin levels when blood sugar is high (especially after a meal) and reduces the amount of sugar made by the body.
Linagliptin is used alone or in mixture with other medications to improve blood sugar levels in adults with type 2 diabetes mellitus. This medication should be used as part of an overall diabetes management plan that comprise a diet and exercise program.